Medical Oddities: Could multilingualism keep you young? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Medical Oddities: Could multilingualism keep you young?

From multilingual minds to pomegranate hearts, gastric mischief, and swishable tea, science stays delightfully odd.

  • By

  • Teraya Smith

  • August 27, 2026

  • 5 min

Share

Clinical Scorecard: Medical Oddities: Could multilingualism keep you young?

At a Glance

CategoryDetail
ConditionMultilingualism and Aging
Key MechanismsAssociation between multilingualism and reduced odds of accelerated aging.
Target PopulationAdults aged 51 to 90 years without diagnosed dementia.
Care SettingObservational study across 27 European countries.

Key Highlights

  • Multilingualism associated with 54% lower odds of accelerated aging.
  • Monolingualism linked to 2.11 times the odds of accelerated aging.
  • Longitudinally, multilingualism linked to 30% lower risk of accelerated aging.
  • Risk reduction observed with additional languages: 10% for 1, 20% for 2, and 29% for 3 or more.
  • Significant associations across age groups after adjustments.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Hearing impairment, hypertension, and heart disease linked to accelerated aging.

        Patient & Prescribing Data

        Adults aged 51 to 90 years without diagnosed dementia.

        Multilingualism may serve as a protective factor against accelerated aging.

        Clinical Best Practices

        • Encourage language learning as a potential cognitive health strategy.
        • Consider social and environmental factors in aging assessments.

        Related Resources & Content

          Original Source(s)

          Medical Oddities: Could multilingualism keep you young?

          • by Teraya Smith

          • August 27, 2026

          Related Content

          GLP-1 Drugs Tied to Lower Addiction Risk

          In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

          Misdiagnosis Common in Parkinsonian Disorders

          Autopsy-confirmed findings linked diagnostic errors, co-pathology, and genetic variation to distinct pathologic patterns across more than 3,300 donors with Parkinsonian disorders.

          FDA Monthly Preview: Key August Decisions to Watch

          Several FDA decisions across multiple specialties are expected this month.